Pure Global AI
NCT06358664Recruiting

Caffeine and Cataract After Pars Plana Vitrectomy

The Effect of Caffeine Consumption on Cataract Formation After Pars Plana Vitrectomy: a Comparative Study
Vienna Institute for Research in Ocular SurgeryClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Cataract
Drug/Device/Intervention
Pars plana vitrectomy
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Vienna Institute for Research in Ocular Surgery
Location
Vienna, Austria
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Apr 01, 2026
Enrollment
74 participants
Primary outcome

Significant cataract formation at year 1

Summary

Assessment of cataract development in patients with regular caffeine consumption and those
 without caffeine consumption after pars plana vitrectomy.

ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06358664
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06358664 through Pure Global AI's free database. This phase not specified trial is sponsored by Vienna Institute for Research in Ocular Surgery and is currently Recruiting. The study focuses on Cataract. Target enrollment is 74 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.